George A. Miller
#124,991
Most Influential Person Now
George A. Miller's AcademicInfluence.com Rankings
Download Badge
Psychology
Why Is George A. Miller Influential?
(Suggest an Edit or Addition)George A. Miller's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. (1973) (960)
- A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. (1998) (635)
- Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. (1981) (516)
- Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. (1985) (461)
- Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. (1985) (453)
- THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN (1988) (448)
- Kinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression (1999) (422)
- Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. (1972) (419)
- Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells (1997) (320)
- Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. (1973) (284)
- Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line (2000) (283)
- Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. (1974) (267)
- Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease (1999) (265)
- Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency (1987) (264)
- Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. (1973) (244)
- Liver Dendritic Cells Are Less Immunogenic Than Spleen Dendritic Cells because of Differences in Subtype Composition1 (2004) (234)
- The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes (1998) (231)
- Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. (1996) (222)
- OPPORTUNISTIC LYMPHOPROLIFERATIONS ASSOCIATED WITH EPSTEIN-BARR VIRAL DNA IN INFANTS AND CHILDREN WITH AIDS (1985) (219)
- Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. (1989) (206)
- Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. (1996) (202)
- Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye (1982) (201)
- Efficiency of transformation of lymphocytes by Epstein-Barr virus. (1977) (199)
- Central-nervous-system lymphoma related to Epstein-Barr virus. (1983) (194)
- Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA. (1980) (193)
- Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. (1974) (185)
- Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. (1976) (181)
- Lytic cycle switches of oncogenic human gammaherpesviruses. (2007) (155)
- The switch between latency and replication of Epstein-Barr virus. (1990) (152)
- Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. (1986) (149)
- Open Reading Frame 50 Protein of Kaposi's Sarcoma-Associated Herpesvirus Directly Activates the Viral PAN and K12 Genes by Binding to Related Response Elements (2002) (147)
- Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. (1987) (147)
- SITE OF EPSTEIN-BARR VIRUS REPLICATION IN THE OROPHARYNX (1979) (146)
- New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma (1982) (144)
- Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. (1984) (136)
- Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. (1980) (136)
- Kaposi’s Sarcoma-Associated Herpesvirus Encodes a bZIP Protein with Homology to BZLF1 of Epstein-Barr Virus (1999) (133)
- Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses (1977) (131)
- Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. (2002) (131)
- Epstein-Barr virus with heterogeneous DNA disrupts latency (1984) (130)
- Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. (1998) (129)
- Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes (1999) (120)
- Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA. (1982) (120)
- A nuclear matrix attachment region organizes the Epstein‐Barr viral plasmid in Raji cells into a single DNA domain. (1992) (117)
- Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. (1987) (114)
- A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. (1982) (114)
- Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation (2003) (114)
- Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. (1983) (110)
- Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus (1989) (110)
- Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. (1988) (108)
- COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS (1973) (107)
- Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases. (1983) (106)
- Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. (1983) (103)
- Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites (2001) (102)
- Establishment of Cell Lines from Normal Adult Human Blood Leukocytes by Exposure to Epstein-Barr Virus and Neutralization by Human Sera with Epstein-Barr Virus Antibody 1 (1971) (96)
- Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen (1997) (94)
- Histone Hyperacetylation Occurs on Promoters of Lytic Cycle Regulatory Genes in Epstein-Barr Virus-Infected Cell Lines Which Are Refractory to Disruption of Latency by Histone Deacetylase Inhibitors (2008) (92)
- Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. (1998) (88)
- Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA (1992) (87)
- CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation (2001) (83)
- Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases (2016) (83)
- The oncogenicity of Epstein-Barr virus. (1974) (82)
- Epstein-Barr virus and nonhuman primates: natural and experimental infection. (1976) (80)
- Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. (1987) (77)
- STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells (2018) (77)
- Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study. (1990) (75)
- Murine Flt3 Ligand Expands Distinct Dendritic Cells with Both Tolerogenic and Immunogenic Properties 1 (2003) (73)
- An Sp1 Response Element in the Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50 Promoter Mediates Lytic Cycle Induction by Butyrate (2005) (72)
- Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus (1987) (71)
- Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Overexpression In Vivo Results in the Long-Term Recruitment of a Distinct Dendritic Cell Population with Enhanced Immunostimulatory Function1 (2002) (70)
- Protein Kinase C-Independent Activation of the Epstein-Barr Virus Lytic Cycle (2002) (68)
- Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. (1982) (68)
- Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells (1976) (68)
- Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters. (1983) (67)
- Detection of Epstein‐Barr virus in the brain by the polymerase chain reaction (1992) (66)
- Two Subclasses of Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle Promoters Distinguished by Open Reading Frame 50 Mutant Proteins That Are Deficient in Binding to DNA (2005) (66)
- High Prevalence of Antibodies to Human Herpesvirus 8 in Relatives of Patients with Classic Kaposi's Sarcoma from Sardinia (1998) (65)
- Genome of a mononucleosis epstein-barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates (1981) (63)
- Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency (1997) (63)
- Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys. (1982) (62)
- Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system. (1986) (59)
- Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras (1996) (58)
- Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. (1984) (58)
- Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses (1989) (58)
- Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. (1985) (57)
- Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. (1971) (57)
- Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta (2004) (55)
- Amino Acid Substitutions Reveal Distinct Functions of Serine 186 of the ZEBRA Protein in Activation of Early Lytic Cycle Genes and Synergy with the Epstein-Barr Virus R Transactivator (1999) (55)
- Primary central nervous system lymphoma related to Epstein‐Barr virus in a patient with acquired immune deficiency syndrome (1986) (55)
- ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter (1991) (53)
- Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts. (1988) (50)
- Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. (1972) (50)
- Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. (1979) (50)
- Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. (1985) (50)
- Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation. (1993) (49)
- Activation and Repression of Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycles by Short- and Medium-Chain Fatty Acids (2014) (49)
- A Functionally Distinct TATA Box Required for Late Progression through the Epstein-Barr Virus Life Cycle (1998) (47)
- De Novo Protein Synthesis Is Required for Lytic Cycle Reactivation of Epstein-Barr Virus, but Not Kaposi's Sarcoma-Associated Herpesvirus, in Response to Histone Deacetylase Inhibitors and Protein Kinase C Agonists (2007) (47)
- Latent herpesviruses of humans. (1984) (47)
- Overexpression of interleukin‐12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity (2003) (47)
- Upregulation of STAT3 Marks Burkitt Lymphoma Cells Refractory to Epstein-Barr Virus Lytic Cycle Induction by HDAC Inhibitors (2009) (47)
- Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis (1997) (47)
- Vaccinia Virus Replication and Cytopathic Effect in Cultures of Phytohemagglutinin-treated Human Peripheral Blood Leukocytes (1968) (47)
- Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels (2020) (46)
- Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus. (1987) (46)
- Autoregulation of DNA Binding and Protein Stability of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein (2004) (46)
- Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. (2003) (45)
- Marked Variation in Response of Consensus Binding Elements for the Rta Protein of Epstein-Barr Virus (2005) (45)
- Establishment of Lines from Normal Human Blood Leukocytes by Co-cultivation with a Leukocyte Line Derived from a Leukemic Child 1 (1969) (44)
- Epstein-Barr viral DNA: infectivity for human placental cells. (1981) (43)
- GM‐CSF expands dendritic cells and their progenitors in mouse liver (2003) (43)
- P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread (1985) (43)
- Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic Cycle (2011) (43)
- Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus (2003) (42)
- In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens. (1993) (40)
- Viral Serology (Hepatitis B Virus, Cytomegalovirus, Epstein‐Barr Virus) and Abnormal Liver Function Tests in Transfused Patients with Hereditary Hemorrhagic Diseases (1979) (40)
- Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons. (1998) (40)
- Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. (1988) (38)
- T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages. (1987) (37)
- Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines. (2008) (36)
- EPSTEIN-BARR VIRUS : HETEROPHILE RESPONSES IN SQUIRREL MONKEYS INOCULATED WITH VIRUS-TRANSFORMED AUTOLOGOUS LEUKOCYTES (1973) (36)
- Immortalization of human lymphocytes by Epstein-Barr virus. (1982) (35)
- Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein (1986) (34)
- Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals. (2006) (34)
- The switch between EBV latency and replication. (1989) (34)
- Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication (1985) (34)
- High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. (1998) (33)
- A Locus Encompassing the Epstein-Barr Virus bglf4 Kinase Regulates Expression of Genes Encoding Viral Structural Proteins (2014) (33)
- Disruption of Epstein-Barr Virus Latency in the Absence of Phosphorylation of ZEBRA by Protein Kinase C (2002) (33)
- Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21) (1996) (32)
- Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells. (1995) (31)
- AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families. (1987) (30)
- Identification of Constitutive Phosphorylation Sites on the Epstein-Barr Virus ZEBRA Protein* (2006) (30)
- Experimental Carcinogenicity by the Virus In Vivo (1979) (29)
- Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus. (1977) (29)
- Essential Role of Rta in Lytic DNA Replication of Epstein-Barr Virus (2012) (28)
- Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA (1986) (28)
- Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids. (1990) (27)
- Epstein-Barr Viral Antigen in Single Cell Clones of Two Human Leukocytic Lines (1970) (27)
- Radiobiological Inactivation of Epstein-Barr Virus (1978) (27)
- PREVALENCE OF ANTIBODIES TO HUMAN HERPESVIRUS 8 (HHV-8) IN SAUDI ARABIAN PATIENTS WITH AND WITHOUT RENAL FAILURE1234 (2001) (27)
- N-linked Glycosylation Is Required for Optimal Function of Kaposi's Sarcoma Herpesvirus–encoded, but Not Cellular, Interleukin 6 (2004) (26)
- Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein. (2010) (26)
- Stimulus Duration and Response Time Independently Influence the Kinetics of Lytic Cycle Reactivation of Epstein-Barr Virus (2009) (25)
- Amino Acids in the Basic Domain of Epstein-Barr Virus ZEBRA Protein Play Distinct Roles in DNA Binding, Activation of Early Lytic Gene Expression, and Promotion of Viral DNA Replication (2006) (25)
- Sequences of the Epstein-Barr Virus (EBV) Large Internal Repeat Form the Center of a 16-Kilobase-Pair Palindrome of EBV (P3HR-1) Heterogeneous DNA (1987) (25)
- Cellular Immediate-Early Gene Expression Occurs Kinetically Upstream of Epstein-Barr Virus bzlf1 and brlf1 following Cross-Linking of the B Cell Antigen Receptor in the Akata Burkitt Lymphoma Cell Line (2010) (25)
- Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments (1981) (24)
- Phosphoacceptor Site S173 in the Regulatory Domain of Epstein-Barr Virus ZEBRA Protein Is Required for Lytic DNA Replication but Not for Activation of Viral Early Genes (2007) (24)
- Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA. (1992) (23)
- Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light. (1977) (23)
- Trypsinized Placental Cell Cultures for the Propagation of Viruses and as “Feeder Layers” (1970) (22)
- Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1 (1990) (22)
- Epstein-Barr virus genomes are restricted to secondary neoplastic cells following bone marrow transplantation. (1985) (22)
- A Subset of Replication Proteins Enhances Origin Recognition and Lytic Replication by the Epstein-Barr Virus ZEBRA Protein (2010) (21)
- Fatal encephalitis due to Herpesvirus hominis: use of intact brain cells for isolation of virus. (1972) (21)
- Infectious mononucleosis: a polyclonal B cell transformation in vivo. (1984) (21)
- A Mobile Functional Region of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein Independently Regulates DNA Binding and Protein Abundance (2008) (20)
- Sequences of the Epstein-Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA (1987) (20)
- Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments. (2008) (19)
- Epstein-Barr virus--immortalization and replication. (1984) (19)
- DNA Damage Signaling Is Induced in the Absence of Epstein—Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA (2015) (19)
- Latency of Epstein–Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA (2013) (19)
- Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. (2007) (19)
- Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody (1982) (17)
- Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene (1984) (17)
- Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. (1994) (17)
- Activation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae (1994) (16)
- Some recent developments in the molecular epidemiology of Epstein-Barr virus infections. (1987) (16)
- Immortalizing and nonimmortalizing laboratory strains of Epstein-Barr Virus. (1975) (16)
- Epstein-Barr herpesvirus and infectious mononucleosis. (1975) (16)
- Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA (1985) (16)
- Direct visualization of enveloped Epstein-Barr Herpesvirus in throat washing with leukocyte-transforming activity. (1975) (16)
- Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA (1997) (16)
- Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells (1993) (16)
- Kaposi ’ s Sarcoma-Associated Herpesvirus Open Reading Frame 50 / Rta Protein Activates the Entire Viral Lytic Cycle in the HHB 2 Primary Effusion Lymphoma Cell Line † (2000) (15)
- Biology of Lymphoid Cells Transformed by Epstein—Barr Virus (1982) (15)
- Cross-neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera. (1979) (15)
- Transfection of human lymphoblastoid cells with herpes simplex viral DNA. (1979) (15)
- Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus. (2000) (14)
- Kinetics of the antibody response to BamHI-K nuclear antigen in uncomplicated infectious mononucleosis. (1986) (14)
- Nuclear Translocation and Regulation of Intranuclear Distribution of Cytoplasmic Poly(A)-Binding Protein Are Distinct Processes Mediated by Two Epstein Barr Virus Proteins (2014) (14)
- Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus (2016) (14)
- Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA (2018) (14)
- Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus (1979) (14)
- Mood stabilizers inhibit cytomegalovirus infection. (2016) (13)
- Prospective study of Epstein-Barr virus infections in acute lymphoblastic leukemia of childhood. (1972) (13)
- Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay. (1995) (13)
- Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1. (1996) (13)
- The transcriptional activator Sp1, a novel autoantigen. (1997) (12)
- Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin. (1988) (12)
- Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses. (1992) (12)
- Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children (1991) (12)
- Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latency. (1993) (11)
- Quantitative leukoviremia and immune complex-dissociated antigenemia as predictors of infection status in children born to mothers infected with human immunodeficiency virus type 1. (1993) (11)
- Genetically and epidemiologically related “non‐syncytium‐inducing” isolates of HIV‐1 display heterogeneous growth patterns in macrophages (2000) (10)
- Efficient Induction of Nuclear Aggresomes by Specific Single Missense Mutations in the DNA-binding Domain of a Viral AP-1 Homolog* (2011) (10)
- Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication (2018) (10)
- Natural killer cell depletion confounds the antitumor mechanism of endogenous IL‐12 overexpression (2004) (8)
- Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function. (2009) (8)
- Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells (1995) (8)
- A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation (2019) (8)
- Susceptibility of human lymphoblastoid cell lines to a cytopathic effect induced by an arginine-utilizing mycoplasma strain. (1971) (8)
- Epstein-Barr virus infections. (2004) (8)
- Complex N-Linked Glycans on Asn-89 of Kaposi Sarcoma Herpes Virus-encoded Interleukin-6 Mediate Optimal Function by Affecting Cytokine Protein Conformation* (2009) (8)
- Properties of Epstein-Barr Virus Transformed Woolly Monkey Lymphoblastoid Cell Lines (1978) (6)
- Epstein-Barr viral nuclear antigen (EBNA) in tumor cell imprints of experimental lymphoma of marmosets. (1974) (6)
- Copy number and location of Epstein-Barr Viral genomes in neonatal human lymphocytes transformed after separation by size and treatment with mitogens. (1981) (6)
- Resistance of neonatal human lymphoid cells to infection by herpes simplex virus overcome by aging cells in culture. (1981) (6)
- Progressive Epstein-Barr Virus Infection (1986) (6)
- The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3. (1997) (6)
- A human B-lymphoblastoid cell line constitutively producing Epstein-Barr herpesvirus and JHK retrovirus. (1997) (6)
- Tissue Culture Contamination with Nontuberculous Mycobacteria (1983) (5)
- Epstein-Barr Virus WZhet DNA Can Induce Lytic Replication in Epithelial Cells in vitro, although WZhet Is Not Detectable in Many Human Tissues in vivo (2009) (5)
- Epidemiology of Burkitt Lymphoma (1976) (5)
- Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment (1986) (4)
- Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference. (1975) (4)
- P3HR-1Epstein-Barr Virus withHeterogeneous DNA Isan Independent Replicon Maintained byCell-to-Cell Spread (1985) (4)
- AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families: clinical experience at Yale-New Haven Hospital. (1987) (3)
- Virus-like rods in a lymphoid line from an infant with AIDS. (1984) (3)
- HETEROPHILE RESPONSES IN SQUIRREL MONKEYS INOCULATED WITH ~flRuS-TRANSFORMED AUTOLOGOUS LEUKOCYTES* (1973) (2)
- How Zebra, A Weak Transactivator, Exerts Strong Biologic Effects (1991) (2)
- Serum IgA to Epstein‐Barr virus Early Antigen‐Diffuse identifies Hodgkin's lymphoma (2014) (2)
- Expression of Epstein-Barr Viral Capsid, Complement Fixing, and Nuclear Antigens in Stationary and Exponential Phase Cultures (1974) (2)
- Regulation of Expression, Mode of Action and Downstream Targets of ORF50 Protein in KSHV Lytic Cycle Activation (2009) (1)
- CD4 1 T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation (2001) (1)
- An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed. (1985) (1)
- Some aspects of the biologic behavior of Epstein-Barr virus. (1976) (1)
- Book Review Epstein–Barr Virus Edited by Erle S. Robertson. 770 pp., illustrated. Wymondham, England, Caister Academic Press, 2005. $300. 1-904455-03-4 (2006) (1)
- Heterodimers of the Zebra and Fos Basic Domains Bind DNA with the Specificity of Zebra (1991) (1)
- EB virus: malignant lymphoma in cottontop marmosets following inoculation and recovery of the virus from cells of an experimental tumor maintained in organ culture. (1975) (1)
- Molecular approaches to epidemiologic evaluation of viruses as risk factors for patients who have chronic fatigue syndrome. (1991) (1)
- Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines. (1978) (1)
- virus-derived autologous lymphoblastoid cell lines Repertoire and frequency of immune cells reactive to Epstein-Barr (2013) (0)
- Immunogenic Properties Dendritic Cells with Both Tolerogenic and Murine Flt3 Ligand Expands Distinct (2013) (0)
- T-Cell-mediated Tumor Protection Immunostimulatory Properties and Induces Natural Killer and Adenovirus Infection Enhances Dendritic Cell (2013) (0)
- The Association of Epstein-Barr Virus with Lymphoproliferative Disorders: A Re-evaluation Using the Polymerase Chain Reaction (1991) (0)
- Interaction of EBV Genes with Human Epithelial Cells (1991) (0)
- Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1 (gene transfer/cell (0)
- Influences ofBurkitt's LymphomaandPrimary B Cells on Latent GeneExpression bytheNonimmortalizing P3J-HR-1 Strain ofEpstein-Barr Virus (1989) (0)
- 1119 INFECTION WITH MULTIPLE EB VIRUS (EBV) GENOTYPES IN AN INFANT WITH AIDS AND HIS MOTHER (1985) (0)
- Receptor on SJL / J NK Cells The NKR-P 1 B Gene Product Is an Inhibitory (1999) (0)
- Epstein-Barr Viral Antigen inSingle CellClones ofTwoHumanLeukocytic Lines (1970) (0)
- Cellular Genes Involved in Redox Regulation Are Altered by Inhibitors of Epstein‐Barr Virus Lytic Gene Expression (2019) (0)
- Animal model for Epstein-Barr lymphoma (1986) (0)
- Award Number: W81XWH-12-1-0313 TITLE: Divergent Effects of Dendritic Cells on Pancreatitis PRINCIPAL INVESTIGATOR: Dr. George Miller CONTRACTING ORGANIZATION: New York University (2015) (0)
- CELLULAR TROPISM AND LEVELS OF VIRAL GENE EXPRESSION DISTINGUISH HHV-8 INVOLVEMENT IN KS, PEL AND MCD (1999) (0)
- Enhanced Immunostimulatory Function of a Distinct Dendritic Cell Population with Vivo Results in the Long-Term Recruitment InColony-Stimulating Factor Overexpression Endogenous Granulocyte-Macrophage (2002) (0)
- #412 Epstein-Barr virus associated diseases, pathogenesis and novel approaches to therapy (1997) (0)
- OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR VIRUS BY PATIENTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS (1974) (0)
- lymphoblastic leukemia virus genomes following allogeneic marrow grafting for acute A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr (2011) (0)
- ZEBRA anda Fos-GCN4Chimeric Protein DNA-Binding Specificities forSites inthe VirusBZLF1Promoter Differ inTheir Epstein-Barr (1991) (0)
- Role of The Zebra Protein in the Switch Between Epstein-Barr Virus Latency and Replication (1989) (0)
- Release ofInfectious Epstein-Barr VirusbyTransformed MarmosetLeukocytes (humanleukocytes/extracellular virus) (1973) (0)
- Epstein-Barr Virus: Transformation, Cytc in Squirrel Monkey and Marmoset Leuko, (2016) (0)
- derived autologous lymphoblastoid cell lines - Repertoire and frequency of immune cells reactive to Epstein-Barr virus (2013) (0)
- REVERSAL OF SIGNS AND SYMPTOMS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) WITH PREDNISONE (1984) (0)
- EPSTEIN-BARR VIRUS (1973) (0)
- Divergent Effects of Dendritic Cells on Pancreatitis (2013) (0)
- Disruption of Latency by a Fragment of Rearranged EBV DNA: Evidence for Host Cell Regulation (1987) (0)
- Radiobiological inactivation of Epstein-Barr virus. [UV and X radiation] (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With George A. Miller?
George A. Miller is affiliated with the following schools:
